7. Currently, the primary justification for therapeutic cloning is as a means of harvesting embryonic stem cells—a process that ends a human life—for research purposes. Despite years of media hype and billions of dollars dedicated to the venture, embryonic stem cell research (ESCR) has never produced any clinically proven therapies—and likely never will. As the Washington Post
wrote earlier this week, “few experts think that production of stem cells through cloning is likely to be medically useful soon, or possibly ever.” ESCR has been one of the most expensive boondoggles
in biomedical history.